132 related articles for article (PubMed ID: 2106802)
1. Severe hematologic toxicity of valproic acid. A report of four patients.
Ganick DJ; Sunder T; Finley JL
Am J Pediatr Hematol Oncol; 1990; 12(1):80-5. PubMed ID: 2106802
[TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndrome associated with chronic valproic acid therapy: a case report and review of the literature.
Allan RW
Hematology; 2007 Dec; 12(6):493-6. PubMed ID: 17852444
[TBL] [Abstract][Full Text] [Related]
3. Hematologic manifestations of long-term valproate therapy.
May RB; Sunder TR
Epilepsia; 1993; 34(6):1098-101. PubMed ID: 8243362
[TBL] [Abstract][Full Text] [Related]
4. [Myelodysplastic syndrome in a patient with familial Pelger-Huet anomaly].
Hiraga H; Yabe H; Nagai K; Nakayama S
Rinsho Ketsueki; 1991 Nov; 32(11):1453-7. PubMed ID: 1758052
[TBL] [Abstract][Full Text] [Related]
5. A case report on reversible Pelger-Huët anomaly depending on serum free fraction of valproic acid.
Suzuki K; Hiramoto A; Okumura T
Brain Dev; 2015 Mar; 37(3):344-6. PubMed ID: 24985021
[TBL] [Abstract][Full Text] [Related]
6. Dose-related thrombocytopenia and macrocytic anemia associated with valproate use in bipolar disorder.
Fawcett RG
J Clin Psychiatry; 1997 Mar; 58(3):125. PubMed ID: 9108818
[No Abstract] [Full Text] [Related]
7. Pseudo Pelger-Huët anomaly in myelodysplastic syndrome: hyposegmented apoptotic neutrophil?
Shetty VT; Mundle SD; Raza A
Blood; 2001 Aug; 98(4):1273-5. PubMed ID: 11510471
[No Abstract] [Full Text] [Related]
8. Pseudo-Pelger-Huët anomaly induced by medications: a clinicopathologic study in comparison with myelodysplastic syndrome-related pseudo-Pelger-Huët anomaly.
Wang E; Boswell E; Siddiqi I; Lu CM; Sebastian S; Rehder C; Huang Q
Am J Clin Pathol; 2011 Feb; 135(2):291-303. PubMed ID: 21228370
[TBL] [Abstract][Full Text] [Related]
9. Haematological disturbances during long-term valproate therapy.
Brichard B; Vermylen C; Scheiff JM; Ninane J; Cornu G
Eur J Pediatr; 1994 May; 153(5):378-80. PubMed ID: 8033931
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome.
Kuriyama K; Tomonaga M; Matsuo T; Ginnai I; Ichimaru M
Br J Haematol; 1986 Aug; 63(4):665-9. PubMed ID: 3460627
[TBL] [Abstract][Full Text] [Related]
11. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
12. Translocations (5;17) and (7;17) in patients with de novo or therapy-related myelodysplastic syndromes or acute nonlymphocytic leukemia. A possible association with acquired pseudo-Pelger-Huët anomaly and small vacuolated granulocytes.
Laï JL; Zandecki M; Fenaux P; Le Baron F; Bauters F; Cosson A; Deminatti M
Cancer Genet Cytogenet; 1990 Jun; 46(2):173-83. PubMed ID: 2340488
[TBL] [Abstract][Full Text] [Related]
13. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
14. Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid.
Pilatrino C; Cilloni D; Messa E; Morotti A; Giugliano E; Pautasso M; Familiari U; Cappia S; Pelicci PG; Lo Coco F; Saglio G; Guerrasio A
Cancer; 2005 Jul; 104(1):101-9. PubMed ID: 15895376
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplasia associated with Turner syndrome.
Foster LA; Abboud MR; Taylor AB; Barredo J; Lazarchick J; Laver J
J Pediatr Hematol Oncol; 1996 Aug; 18(3):299-301. PubMed ID: 8689346
[TBL] [Abstract][Full Text] [Related]
16. Valproic acid and thrombocytopenia: cross-sectional study.
Ko CH; Kong CK; Tse PW
Hong Kong Med J; 2001 Mar; 7(1):15-21. PubMed ID: 11406671
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin for treatment of myelodysplastic syndromes.
Rafanelli D; Grossi A; Longo G; Vannucchi AM; Bacci P; Ferrini PR
Leukemia; 1992 Apr; 6(4):323-7. PubMed ID: 1588794
[TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic syndrome in two dogs.
Weiss DJ; Raskin R; Zerbe C
J Am Vet Med Assoc; 1985 Nov; 187(10):1038-40. PubMed ID: 4066460
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow changes mimicking myelodysplasia in patients with hemophagocytic lymphohistiocytosis.
Imashuku S; Kitazawa K; Ishii M; Kataoka S; Asami K; Ishii E; Fukushima K; Sako M; Matsubayashi T; Teramura GT; Hibi S
Int J Hematol; 2000 Oct; 72(3):353-7. PubMed ID: 11185994
[TBL] [Abstract][Full Text] [Related]
20. Hypoplastic myelodysplastic syndrome.
Nand S; Godwin JE
Cancer; 1988 Sep; 62(5):958-64. PubMed ID: 3409176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
